Stock Titan Trading tools for traders and investors.

-

08:18:23 AM

Last SENS Stock Market News

SENS - Senseonics Holdings Inc

03/04/21 4:05 PM

NYSE : SENS

Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported financial results for the quarter and full year ended

RHEA-AI

neutral

03/02/21 5:29 PM

NYSE : SENS

Senseonics to Participate in the H.C. Wainwright Global Life Sciences Conference

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming virtual H.C. Wainwright

RHEA-AI

neutral

02/19/21 8:00 AM

NYSE : SENS

Senseonics Holdings, Inc. Schedules Fourth Quarter and Full Year 2020 Earnings Release and Conference Call for March 4, 2021 at 4:30 p.m. Eastern Time

Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it plans to release its fourth quarter and full year

RHEA-AI

neutral

02/11/21 4:05 PM

NYSE : SENS

Senseonics to Participate in the SVB Leerink Global Healthcare Conference

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming virtual SVB Leerink

RHEA-AI

neutral

02/01/21 8:00 AM

NYSE : SENS

Senseonics Announces Initiation of European Commercial Efforts by Partner Ascensia Diabetes Care

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that Ascensia Diabetes Care (Ascensia) has commenced sales

RHEA-AI

very positive

01/28/21 11:33 PM

NYSE : SENS

Senseonics Holdings Announces Closing of $115.0 Million Bought Deal Offering of Common Stock and Full Exercise of the Option to Purchase Additional Shares

Senseonics Holdings, Inc. (NYSE American: SENS) ("Senseonics" or the "Company"), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced the closing on January 26,

RHEA-AI

neutral

01/22/21 12:18 AM

NYSE : SENS

Senseonics Holdings Increases Previously Announced Bought Deal Offering of Common Stock to $100.0 Million

Senseonics Holdings, Inc. (NYSE American: SENS) ("Senseonics" or the "Company"), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced that, due to demand, the

RHEA-AI

very positive

01/21/21 5:13 PM

NYSE : SENS

Senseonics Holdings Announces $50.0 Million Bought Deal Offering of Common Stock

Senseonics Holdings, Inc. (NYSE American: SENS) ("Senseonics" or the "Company"), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced that it has entered into an

RHEA-AI

neutral

01/19/21 8:00 AM

NYSE : SENS

Senseonics Announces a Positive Coverage Decision for Eversense CGM from EmblemHealth

Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, announced today that EmblemHealth is now providing coverage for the

RHEA-AI

neutral

01/17/21 10:22 PM

NYSE : SENS

Senseonics Holdings Announces $50.0 Million Registered Direct Offering of Common Stock

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it has entered into securities purchase agreements with

RHEA-AI

neutral